Survey of primary liver tumors and oral contraceptive use

Over the past few years an association between oral contraceptive use and liver tumors has been suggested, and this is now being studied on an epidemiological basis. Large scale retrospective studies to date support a relationship between oral contraceptive use and benign liver tumors. These tumors carry a significant risk of spontaneous rupture. The possible relationship with malignant liver tumors is also discussed. Clinical aspects of these tumors are presented, as well as suspected oncogenic mechanisms.

Download Full-text

Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study

The European Journal of Contraception & Reproductive Health Care ◽

10.3109/13625189809167253 ◽

1998 ◽

Vol 3 (4) ◽

pp. 194-200 ◽

Cited By ~ 41

Author(s):

L. A. J. Heinemann ◽

A. Weimann ◽

G. Gerken ◽

C. Thiel ◽

M. Schlaud ◽

...

Keyword(s):

Oral Contraceptive ◽

Contraceptive Use ◽

Case Control Study ◽

Liver Tumors ◽

Case Control ◽

Benign Liver Tumors ◽

Oral Contraceptive Use ◽

Benign Liver Tumor ◽

Benign Liver ◽

Control Study

Download Full-text

Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors

Journal of Surgical Oncology ◽

10.1002/jso.2930180112 ◽

1981 ◽

Vol 18 (1) ◽

pp. 73-85 ◽

Cited By ~ 16

Author(s):

Curtis Mettlin ◽

Nachimuthu Natarajan

Keyword(s):

Oral Contraceptive ◽

Contraceptive Use ◽

Liver Tumors ◽

Oral Contraceptive Use ◽

Malignant Liver Tumors ◽

Malignant Liver

Download Full-text

The Role of Hepatobiliary Scintigraphy in the Follow-up of Benign Liver Tumors Secondary to Oral Contraceptive Use

Clinical Nuclear Medicine ◽

10.1097/00003072-200111000-00016 ◽

2001 ◽

Vol 26 (11) ◽

pp. 946-947

Author(s):

SERGEY BYKOV ◽

IZAK GARTY ◽

LEONID CHEREVINSKY ◽

ORI SEGOL ◽

DIMITRY LUMELSKY

Keyword(s):

Oral Contraceptive ◽

Contraceptive Use ◽

Liver Tumors ◽

Hepatobiliary Scintigraphy ◽

Benign Liver Tumors ◽

Oral Contraceptive Use ◽

Benign Liver

Download Full-text

Oral Contraceptive Use and Risk of Early-Onset Breast Cancer in Carriers and Noncarriers of BRCA1 and BRCA2 Mutations

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70471-5 ◽

2006 ◽

Vol 2006 ◽

pp. 269-270

Author(s):

L.P. Shulman

Keyword(s):

Breast Cancer ◽

Oral Contraceptive ◽

Early Onset ◽

Contraceptive Use ◽

Early Onset Breast Cancer ◽

Brca1 And Brca2 ◽

Oral Contraceptive Use ◽

Brca2 Mutations ◽

Brca1 And Brca2 Mutations

Download Full-text

Oral Contraceptive Use Linked to Development of Atherosclerosis

Cardiology News ◽

10.1016/s1544-8800(07)70385-8 ◽

2007 ◽

Vol 5 (10) ◽

pp. 10

Author(s):

MITCHEL L. ZOLER

Keyword(s):

Oral Contraceptive ◽

Contraceptive Use ◽

Oral Contraceptive Use

Download Full-text

Plasminogen Activator Levels in Plasma and Urine during Exercise and Oral Contraceptive Use

Thrombosis and Haemostasis ◽

10.1055/s-0038-1646751 ◽

1978 ◽

Vol 39 (03) ◽

pp. 743-750 ◽

Cited By ~ 5

Author(s):

Anne M Hedlin ◽

Susan Milojevic ◽

Andrew Korey

Keyword(s):

Oral Contraceptive ◽

Plasminogen Activator ◽

Contraceptive Use ◽

Ethinyl Estradiol ◽

Plasminogen Activators ◽

Oral Contraceptive Use ◽

Ethynodiol Diacetate

SummaryThe effect of Demulen (ethinyl estradiol 0.05 mg and ethynodiol diacetate 1 mg) and exercise on the level of plasminogen activators was studied in 25 women (12 controls and 13 contraceptive users).Plasma plasminogen activator level was increased by the use of the oral contraceptive and further increased by exercise. Urine plasminogen activator level was unchanged by the use of Demulen but, in both groups of subjects, was decreased by exercise.

Download Full-text